{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T19:36:46Z","timestamp":1775936206734,"version":"3.50.1"},"reference-count":171,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.ejphar.2005.12.055","type":"journal-article","created":{"date-parts":[[2006,2,11]],"date-time":"2006-02-11T12:14:43Z","timestamp":1139660083000},"page":"182-194","source":"Crossref","is-referenced-by-count":81,"title":["Novel concepts of neuropeptide-based drug therapy: Vasoactive intestinal polypeptide and its receptors"],"prefix":"10.1016","volume":"533","author":[{"given":"David A.","family":"Groneberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus F.","family":"Rabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.12.055_bib1","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0006-291X(87)80293-0","article-title":"Selective localization of vasoactive intestinal peptide and substance P in human eosinophils","volume":"148","author":"Aliakbari","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2005.12.055_bib2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1152\/jappl.1984.56.4.986","article-title":"Comparison of vasoactive intestinal peptide and isoproterenol relaxant effects in isolated cat airways","volume":"56","author":"Altiere","year":"1984","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1378\/chest.86.1.153","article-title":"Comparative effects of inhaled isoproterenol and vasoactive intestinal peptide on histamine-induced bronchoconstriction in human subjects","volume":"86","author":"Altiere","year":"1984","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2005.12.055_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0014-5793(93)81322-Q","article-title":"Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin","volume":"318","author":"Andersson","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2005.12.055_bib5","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1183\/09031936.01.17509820","article-title":"Epidemiology of chronic obstructive pulmonary disease","volume":"17","author":"Anto","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2005.12.055_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0006-8993(86)90200-3","article-title":"Vasoactive intestinal polypeptide increases inositol phospholipid breakdown in the rat superior cervical ganglion","volume":"376","author":"Audigier","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2005.12.055_bib7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1183\/09031936.01.17407730","article-title":"Allergy markers in respiratory epidemiology","volume":"17","author":"Baldacci","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2005.12.055_bib8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1172\/JCI114780","article-title":"Vasoactive intestinal peptide in human nasal mucosa","volume":"86","author":"Baraniuk","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2005.12.055_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1164\/arrd.1984.130.2.162","article-title":"The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans","volume":"130","author":"Barnes","year":"1984","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejphar.2005.12.055_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1476-5381.1986.tb11131.x","article-title":"Vasoactive intestinal peptide in bovine pulmonary artery: localisation, function and receptor autoradiography","volume":"89","author":"Barnes","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1183\/09031936.03.00040703","article-title":"Chronic obstructive pulmonary disease: molecular and cellular mechanisms","volume":"22","author":"Barnes","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2005.12.055_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1094-5539(02)00180-3","article-title":"Sensory nerves and airway inflammation: role of A delta and C-fibres","volume":"16","author":"Belvisi","year":"2003","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2005.12.055_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/pupt.2001.0337","article-title":"New evidence for transmitter role of VIP in the airways: impaired relaxation by a catalytic antibody","volume":"15","author":"Berisha","year":"2002","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2005.12.055_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1399-3011.1993.tb00122.x","article-title":"Structure-activity studies of vasoactive intestinal peptide (VIP): cyclic disulfide analogs","volume":"41","author":"Bolin","year":"1993","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.ejphar.2005.12.055_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1399-3011.1995.tb00599.x","article-title":"Structure-activity studies on the vasoactive intestinal peptide pharmacophore. 1. Analogs of tyrosine","volume":"46","author":"Bolin","year":"1995","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.ejphar.2005.12.055_bib16","first-page":"107","article-title":"Comparison of cyclic and linear analogs of vasoactive intestinal peptide","volume":"13","author":"Bolin","year":"1996","journal-title":"Drug Des. Discov."},{"key":"10.1016\/j.ejphar.2005.12.055_bib17","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(00)03497-8","article-title":"Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Bryan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2005.12.055_bib18","first-page":"427","article-title":"Pretreatment of exercise-induced asthma with inhaled vasoactive intestinal peptide (VIP)","volume":"128","author":"Bundgaard","year":"1983","journal-title":"Eur. J. Respir. Dis. Suppl."},{"key":"10.1016\/j.ejphar.2005.12.055_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0196-9781(99)00202-8","article-title":"Immunohistochemical localization and distribution of VIP\/PACAP receptors in human lung","volume":"21","author":"Busto","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2005.12.055_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1113\/expphysiol.1983.sp002735","article-title":"The quest for the inhibitory neurotransmitter in bovine tracheal smooth muscle","volume":"68","author":"Cameron","year":"1983","journal-title":"Q. J. Exp. Physiol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0968-0004(00)88978-1","article-title":"Parallel signal processing among mammalian MAPKs","volume":"20","author":"Cano","year":"1995","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2005.12.055_bib22","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1183\/09031936.94.07122169","article-title":"Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma","volume":"7","author":"Cardell","year":"1994","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2005.12.055_bib23","first-page":"249","article-title":"Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung","volume":"239","author":"Carstairs","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.12.055_bib24","first-page":"133","article-title":"Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase","volume":"244","author":"Caughey","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.12.055_bib25","doi-asserted-by":"crossref","first-page":"50s","DOI":"10.1183\/09031936.01.00229701","article-title":"Cytokines in chronic obstructive pulmonary disease","volume":"34","author":"Chung","year":"2001","journal-title":"Eur. Respir. J. Suppl."},{"key":"10.1016\/j.ejphar.2005.12.055_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0167-0115(94)90537-1","article-title":"Properties of the VIP-PACAP type II receptor stably expressed in CHO cells","volume":"54","author":"Ciccarelli","year":"1994","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2005.12.055_bib27","first-page":"531","article-title":"Inhibition by vasoactive intestinal peptide of glycoconjugate and lysozyme secretion by human airways in vitro","volume":"124","author":"Coles","year":"1981","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejphar.2005.12.055_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1006\/bbrc.1994.1517","article-title":"Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains","volume":"200","author":"Couvineau","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2005.12.055_bib29","first-page":"A249","article-title":"Inhaled vasoactive intestinal peptide (VIP) prevents bronchoconstriction induced by inhaled histamine","volume":"127","author":"Cox","year":"1983","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejphar.2005.12.055_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/275661a0","article-title":"Release of vasoactive intestinal polypeptide in mast cells by histamine liberators","volume":"275","author":"Cutz","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2005.12.055_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1471-4906(03)00069-3","article-title":"VIP: a very important peptide in T helper differentiation","volume":"24","author":"Delgado","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib32","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.4049\/jimmunol.166.5.2907","article-title":"Cutting edge: is vasoactive intestinal peptide a type 2 cytokine?","volume":"166","author":"Delgado","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib33","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1096\/fj.02-0799fje","article-title":"Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation","volume":"17","author":"Delgado","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2005.12.055_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-5728(96)00063-X","article-title":"Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes","volume":"68","author":"Delgado","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib35","doi-asserted-by":"crossref","first-page":"31427","DOI":"10.1074\/jbc.273.47.31427","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein\/c-Jun","volume":"273","author":"Delgado","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2005.12.055_bib36","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.4049\/jimmunol.162.4.2358","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies","volume":"162","author":"Delgado","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/87887","article-title":"Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease","volume":"7","author":"Delgado","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2005.12.055_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1749-6632.2003.tb03145.x","article-title":"PACAP in immunity and inflammation","volume":"992","author":"Delgado","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2005.12.055_bib39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00210505","article-title":"Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cat, and human subjects","volume":"220","author":"Dey","year":"1981","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejphar.2005.12.055_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0306-4522(88)90330-2","article-title":"Co-localization of vasoactive intestinal peptide- and substance P-containing nerves in cat bronchi","volume":"24","author":"Dey","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2005.12.055_bib42","first-page":"827","article-title":"In vivo bronchodilator activity of vasoactive intestinal peptide in the cat","volume":"128","author":"Diamond","year":"1983","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejphar.2005.12.055_bib41","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1183\/09031936.98.12061454","article-title":"Regulation of airway neurogenic inflammation by neutral endopeptidase","volume":"12","author":"Di Maria","year":"1998","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2005.12.055_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-2999(02)02237-9","article-title":"Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness","volume":"452","author":"Eynott","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/jpet.102.040295","article-title":"Role of nitric oxide in chronic allergen-induced airway cell proliferation and inflammation","volume":"304","author":"Eynott","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.12.055_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1476-5381.1990.tb12054.x","article-title":"Effects of epithelium removal on relaxation of airway smooth muscle induced by vasoactive intestinal peptide and electrical field stimulation","volume":"100","author":"Farmer","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib46","doi-asserted-by":"crossref","first-page":"L749","DOI":"10.1152\/ajplung.2001.281.4.L749","article-title":"Regulation of apoptosis by vasoactive peptides","volume":"281","author":"Filippatos","year":"2001","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib47","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.0022-202x.2001.01449.x","article-title":"Abundant expression of vasoactive intestinal polypeptide receptor VPAC2 mRNA in human skin","volume":"117","author":"Fischer","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/pupt.2001.0332","article-title":"Mediators of asthma: nitric oxide","volume":"15","author":"Fischer","year":"2002","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2005.12.055_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1034\/j.1600-0560.2002.290201.x","article-title":"Simultaneous detection of receptor mRNA and ligand protein in human skin tissues","volume":"29","author":"Fischer","year":"2002","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib50","first-page":"506","article-title":"Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase","volume":"34","author":"Francis","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib51","first-page":"947","article-title":"Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret","volume":"248","author":"Franconi","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.12.055_bib52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1476-5381.1978.tb08471.x","article-title":"Vasoactive intestinal polypeptide promotes cyclic adenosine 3\u2032,5\u2032-monophosphate accumulation in guinea-pig trachea","volume":"62","author":"Frandsen","year":"1978","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib53","first-page":"H755","article-title":"Vasoactive intestinal peptide: vasodilatation and cyclic AMP generation","volume":"250","author":"Ganz","year":"1986","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib54","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1210\/endo-111-4-1248","article-title":"Regulatory peptides in the mammalian respiratory tract","volume":"111","author":"Ghatei","year":"1982","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2005.12.055_bib55","doi-asserted-by":"crossref","first-page":"9083","DOI":"10.1016\/S0021-9258(19)76511-9","article-title":"Structurally distinctive vasoactive intestinal peptides from rat basophilic leukemia cells","volume":"263","author":"Goetzl","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2005.12.055_bib56","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/0006-291X(89)92800-3","article-title":"Preferential cleavage of amino- and carboxyl-terminal oligopeptides from vasoactive intestinal polypeptide by human recombinant enkephalinase (neutral endopeptidase, EC 3.4.24.11)","volume":"158","author":"Goetzl","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2005.12.055_bib57","doi-asserted-by":"crossref","first-page":"13854","DOI":"10.1073\/pnas.241503798","article-title":"Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide","volume":"98","author":"Goetzl","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2005.12.055_bib58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1381612013398374","article-title":"Immunology of VIP: a review and therapeutical perspectives","volume":"7","author":"Gomariz","year":"2001","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2005.12.055_bib59","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0196-9781(97)00230-1","article-title":"In vitro properties of a high affinity selective antagonist of the VIP1 receptor","volume":"18","author":"Gourlet","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2005.12.055_bib60","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0196-9781(96)00322-1","article-title":"The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass","volume":"18","author":"Gourlet","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2005.12.055_bib61","first-page":"45","article-title":"Relaxant effects of vasoactive intestinal peptide and peptide histidine isoleucine in human and bovine pulmonary arteries","volume":"24","author":"Greenberg","year":"1987","journal-title":"Blood Vessels"},{"key":"10.1016\/j.ejphar.2005.12.055_bib62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/362155a0","article-title":"Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos","volume":"362","author":"Gressens","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2005.12.055_bib63","first-page":"G774","article-title":"Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP release","volume":"262","author":"Grider","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib64","doi-asserted-by":"crossref","first-page":"G697","DOI":"10.1152\/ajpgi.2001.281.3.G697","article-title":"Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1","volume":"281","author":"Groneberg","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib65","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0304-3940(01)01794-3","article-title":"Expression of PEPT2 peptide transporter mRNA and protein in glial cells of rat dorsal root ganglia","volume":"304","author":"Groneberg","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2005.12.055_bib66","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/labinvest.3780283","article-title":"Expression and distribution of vasoactive intestinal polypeptide receptor VPAC(2) mRNA in human airways","volume":"81","author":"Groneberg","year":"2001","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2005.12.055_bib67","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0002-9440(10)64013-8","article-title":"Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake","volume":"158","author":"Groneberg","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib68","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/pupt.2001.0306","article-title":"Vasoactive intestinal polypeptide as mediator of asthma","volume":"14","author":"Groneberg","year":"2001","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2005.12.055_bib69","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1023\/A:1019810512519","article-title":"Renal assimilation of short chain peptides: visualization of tubular peptide uptake","volume":"19","author":"Groneberg","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2005.12.055_bib70","doi-asserted-by":"crossref","first-page":"E1172","DOI":"10.1152\/ajpendo.00381.2001","article-title":"Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein","volume":"282","author":"Groneberg","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2005.12.055_bib71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/thorax.57.1.55","article-title":"Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung","volume":"57","author":"Groneberg","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2005.12.055_bib72","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2559.2002.01378.x","article-title":"Expression of respiratory mucins in fatal status asthmaticus and mild asthma","volume":"40","author":"Groneberg","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.ejphar.2005.12.055_bib73","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/rmed.2001.1221","article-title":"Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung","volume":"96","author":"Groneberg","year":"2002","journal-title":"Respir. Med."},{"key":"10.1016\/j.ejphar.2005.12.055_bib74","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/01926230309749","article-title":"Toxic rhinitis-induced changes of human nasal mucosa innervation","volume":"31","author":"Groneberg","year":"2003","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib75","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1183\/09031936.03.00086002","article-title":"Aspirin-sensitive rhinitis associated changes in upper airway innervation","volume":"22","author":"Groneberg","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2005.12.055_bib76","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00005537-200303000-00023","article-title":"Distribution of respiratory mucin proteins in human nasal mucosa","volume":"113","author":"Groneberg","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejphar.2005.12.055_bib77","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/rmed.2002.1457","article-title":"Fundamentals of pulmonary drug delivery","volume":"97","author":"Groneberg","year":"2003","journal-title":"Respir. Med."},{"key":"10.1016\/j.ejphar.2005.12.055_bib78","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/01902140490276320","article-title":"Smads as intracellular mediators of airway inflammation","volume":"30","author":"Groneberg","year":"2004","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.ejphar.2005.12.055_bib79","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1165\/rcmb.2003-0315TR","article-title":"Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport","volume":"30","author":"Groneberg","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib80","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjmed.2003.08.023","article-title":"Mucus and fatal asthma","volume":"116","author":"Groneberg","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2005.12.055_bib81","first-page":"406","article-title":"Vasoactive intestinal peptide counteracts leukotriene D4-induced contractions of guinea pig trachea, lung, and pulmonary artery","volume":"96","author":"Hamasaki","year":"1983","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"10.1016\/j.ejphar.2005.12.055_bib82","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1006\/bbrc.2002.6595","article-title":"Genomic organization and regulation of a human 7-helix transmembrane receptor which is expressed in pulmonary epithelial cells and induced in hypoxia","volume":"291","author":"Hanze","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2005.12.055_bib83","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0031-6997(24)01360-7","article-title":"International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide","volume":"50","author":"Harmar","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2005.12.055_bib84","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1378\/chest.124.3.1067","article-title":"Nitric oxide and vasoactive intestinal peptide as co-transmitters of airway smooth-muscle relaxation: analysis in neuronal nitric oxide synthase knockout mice","volume":"124","author":"Hasaneen","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2005.12.055_bib85","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/00043764-200210000-00011","article-title":"Innervation of human nasal mucosa in environmentally triggered hyperreflectoric rhinitis","volume":"44","author":"Heppt","year":"2002","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.ejphar.2005.12.055_bib86","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.322.7280.239","article-title":"New drug discovery techniques are not so revolutionary","volume":"322","author":"Horrobin","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2005.12.055_bib87","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000235396","article-title":"Mucosal nerves in endobronchial biopsies in asthma and non-asthma","volume":"94","author":"Howarth","year":"1991","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib88","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1073\/pnas.91.7.2679","article-title":"Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells","volume":"91","author":"Inagaki","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2005.12.055_bib89","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0896-6273(92)90101-I","article-title":"Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide","volume":"8","author":"Ishihara","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2005.12.055_bib90","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0196-9781(91)90179-S","article-title":"Vasoactive intestinal polypeptide precursors have highly potent bronchodilatory activity","volume":"12","author":"Ito","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2005.12.055_bib91","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1113\/jphysiol.1982.sp014355","article-title":"Non-adrenergic inhibitory nerves and putative transmitters in the smooth muscle of cat trachea","volume":"330","author":"Ito","year":"1982","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.ejphar.2005.12.055_bib92","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-2999(01)01323-1","article-title":"Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists","volume":"429","author":"Joos","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib93","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1183\/09031936.03.00101902","article-title":"Dual tachykinin NK1\/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients","volume":"23","author":"Joos","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2005.12.055_bib94","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1165\/ajrcmb.16.2.9032120","article-title":"Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma","volume":"16","author":"Kaltreider","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib95","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1164\/ajrccm.155.2.9032223","article-title":"Synergistic effect of nitric oxide and vasoactive intestinal peptide on bronchoprotection against histamine in anesthetized guinea pigs","volume":"155","author":"Kanazawa","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2005.12.055_bib96","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1165\/rcmb.4811","article-title":"Pan-neurotrophin receptor p75 contributes to neuronal hyperreactivity and airway inflammation in a murine model of experimental asthma","volume":"28","author":"Kerzel","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib97","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1094-5539(02)00093-7","article-title":"Eosinophil and airway nerve interactions","volume":"16","author":"Kingham","year":"2003","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2005.12.055_bib98","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1183\/09031936.01.17304990","article-title":"New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5","volume":"17","author":"Kips","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2005.12.055_bib99","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00494059","article-title":"VIP like immunoreactive nerves in human respiratory tract. Light and electron microscopic study","volume":"82","author":"Laitinen","year":"1985","journal-title":"Histochemistry"},{"key":"10.1016\/j.ejphar.2005.12.055_bib100","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1164\/ajrccm\/136.6_Pt_2.S59","article-title":"Vascular actions of airway neuropeptides","volume":"136","author":"Laitinen","year":"1987","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejphar.2005.12.055_bib101","doi-asserted-by":"crossref","first-page":"C115","DOI":"10.1152\/ajpcell.1986.251.1.C115","article-title":"cAMP immunocytochemistry provides evidence for functional VIP receptors in trachea","volume":"251","author":"Lazarus","year":"1986","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib102","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3181\/00379727-203-43616","article-title":"Peptidase modulation of airway effects of neuropeptides","volume":"203","author":"Lilly","year":"1993","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2005.12.055_bib103","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1172\/JCI117280","article-title":"Effects of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea pig lungs","volume":"93","author":"Lilly","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2005.12.055_bib104","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1164\/ajrccm.151.2.7531100","article-title":"Neuropeptide content of lungs from asthmatic and nonasthmatic patients","volume":"151","author":"Lilly","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2005.12.055_bib105","doi-asserted-by":"crossref","first-page":"C399","DOI":"10.1152\/ajpcell.1990.258.3.C399","article-title":"cGMP-dependent protein kinase mediates the reduction of Ca2+ by cAMP in vascular smooth muscle cells","volume":"258","author":"Lincoln","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib107","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/thorax.58.3.217","article-title":"Bronchodilation by an inhaled VPAC(2) receptor agonist in patients with stable asthma","volume":"58","author":"Linden","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2005.12.055_bib106","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1073\/pnas.84.2.605","article-title":"Structure and expression of the gene encoding the vasoactive intestinal peptide precursor","volume":"84","author":"Linder","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2005.12.055_bib108","first-page":"1","article-title":"Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands. Morphological, biochemical and functional studies","volume":"496","author":"Lundberg","year":"1981","journal-title":"Acta Physiol. Scand., Suppl."},{"key":"10.1016\/j.ejphar.2005.12.055_bib109","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0016-5085(79)90006-4","article-title":"Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve","volume":"77","author":"Lundberg","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2005.12.055_bib110","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0196-9781(84)90090-1","article-title":"Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man","volume":"5","author":"Lundberg","year":"1984","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2005.12.055_bib111","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1113\/jphysiol.1987.sp016545","article-title":"Lung reflexes and nasal vascular resistance in the anaesthetized dog","volume":"386","author":"Lung","year":"1987","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.ejphar.2005.12.055_bib112","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00239446","article-title":"Peptide-containing nerve fibers in the respiratory tract of the ferret","volume":"258","author":"Luts","year":"1989","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejphar.2005.12.055_bib113","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0014-5793(93)81668-P","article-title":"The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide","volume":"334","author":"Lutz","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2005.12.055_bib114","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0021-9258(18)69179-3","article-title":"Vasoactive intestinal polypeptide and muscarine mobilize intracellular Ca2+ through breakdown of phosphoinositides to induce catecholamine secretion. Role of IP3 in exocytosis","volume":"263","author":"Malhotra","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2005.12.055_bib115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0167-0115(94)90055-8","article-title":"Vasoactive intestinal peptide stimulates a cAMP-mediated CI\u2212 current in avian salt gland cells","volume":"52","author":"Martin","year":"1994","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2005.12.055_bib116","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1748-1716.1989.tb08585.x","article-title":"Effects of neuropeptides and capsaicin on tracheobronchial blood flow of the pig","volume":"135","author":"Matran","year":"1989","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ejphar.2005.12.055_bib117","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1126\/science.6254154","article-title":"Vasoactive intestinal peptide: a possible transmitter of nonadrenergic relaxation of guinea pig airways","volume":"210","author":"Matsuzaki","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2005.12.055_bib118","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(83)91272-2","article-title":"Vasoactive intestinal peptide causes bronchodilatation and protects against histamine-induced bronchoconstriction in asthmatic subjects","volume":"2","author":"Morice","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2005.12.055_bib119","first-page":"294","article-title":"Immunoreactivities of vasoactive intestinal peptide (VIP) and glucagon in leukocytes from leukaemic patients","volume":"99","author":"Murphy","year":"1981","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ejphar.2005.12.055_bib120","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1152\/jappl.1985.58.5.1723","article-title":"Pulmonary vasodilator responses to vasoactive intestinal peptide in the cat","volume":"58","author":"Nandiwada","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib121","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1152\/jappl.1983.55.6.1844","article-title":"Effect of vasoactive intestinal peptide on ion transport across dog tracheal epithelium","volume":"55","author":"Nathanson","year":"1983","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib122","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.4049\/jimmunol.150.12.5281","article-title":"Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements","volume":"150","author":"Nio","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib123","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0196-9781(89)90100-9","article-title":"The effects of various peptides on the isolated pulmonary artery","volume":"10","author":"Obara","year":"1989","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2005.12.055_bib124","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1016\/S0021-9258(18)38130-4","article-title":"Structure-activity studies of vasoactive intestinal polypeptide","volume":"266","author":"O'Donnell","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2005.12.055_bib125","first-page":"1282","article-title":"Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part I: in vitro and in vivo bronchodilator studies","volume":"270","author":"O'Donnell","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.12.055_bib126","first-page":"1289","article-title":"Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: effect on in vitro and in vivo models of pulmonary anaphylaxis","volume":"270","author":"O'Donnell","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.12.055_bib127","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4049\/jimmunol.127.6.2551","article-title":"Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase","volume":"127","author":"O'Dorisio","year":"1981","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1399-3038.1993.tb00061.x","article-title":"Responses of plasma vasoactive intestinal polypeptide to methacholine and exercise loading in children and adolescents with bronchial asthma","volume":"4","author":"Ohzeki","year":"1993","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib129","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJM198905113201904","article-title":"Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma","volume":"320","author":"Ollerenshaw","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2005.12.055_bib130","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1152\/jappl.1986.61.4.1322","article-title":"VIP and PHM and their role in nonadrenergic inhibitory responses in isolated human airways","volume":"61","author":"Palmer","year":"1986","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib131","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/thx.41.9.663","article-title":"Effect of infused vasoactive intestinal peptide on airway function in normal subjects","volume":"41","author":"Palmer","year":"1986","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2005.12.055_bib132","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-5728(89)90032-5","article-title":"Characterization of autoantibodies to vasoactive intestinal peptide in asthma","volume":"23","author":"Paul","year":"1989","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib133","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1164\/arrd.1983.128.1.89","article-title":"Vasoactive intestinal peptide stimulates tracheal submucosal gland secretion in ferret","volume":"128","author":"Peatfield","year":"1983","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejphar.2005.12.055_bib134","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI17500","article-title":"Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension","volume":"111","author":"Petkov","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2005.12.055_bib135","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1210\/en.136.5.2088","article-title":"Differential expression of pituitary adenylate cyclase-activating polypeptide\/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs","volume":"136","author":"Rawlings","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2005.12.055_bib136","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1164\/ajrccm\/136.6_Pt_2.S72","article-title":"The control of mucous secretion in the airways by peptidergic mechanisms","volume":"136","author":"Richardson","year":"1987","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejphar.2005.12.055_bib137","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1128\/MCB.23.9.3247-3252.2003","article-title":"Targeted disruption of the peptide transporter Pept2 gene in mice defines its physiological role in the kidney","volume":"23","author":"Rubio-Aliaga","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib138","first-page":"304","article-title":"Vasoactive intestinal peptide relaxes isolated strips of human bronchus, pulmonary artery, and lung parenchyma","volume":"97","author":"Saga","year":"1984","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"10.1016\/j.ejphar.2005.12.055_bib139","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/01902148209069662","article-title":"Vasoactive peptides in the lung, with special reference to vasoactive intestinal peptide","volume":"3","author":"Said","year":"1982","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.ejphar.2005.12.055_bib140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0197-0186(93)90112-I","article-title":"Vasoactive intestinal peptide: involvement of calmodulin and catalytic antibodies","volume":"23","author":"Said","year":"1993","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2005.12.055_bib141","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.169.3951.1217","article-title":"Polypeptide with broad biological activity: isolation from small intestine","volume":"169","author":"Said","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2005.12.055_bib142","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/225863a0","article-title":"Potent peripheral and splanchnic vasodilator peptide from normal gut","volume":"225","author":"Said","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2005.12.055_bib143","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1748-1716.1989.tb08727.x","article-title":"Vasoactive intestinal peptide (VIP) may reduce the removal rate of cytosolic Ca2+ after transient elevations in clonal rat lactotrophs","volume":"137","author":"Sand","year":"1989","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ejphar.2005.12.055_bib144","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0196-9781(88)90133-7","article-title":"Vasoactive intestinal peptide evokes endothelium-dependent relaxation and cyclic AMP accumulation in rat aorta","volume":"9","author":"Sata","year":"1988","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2005.12.055_bib145","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s002100100458","article-title":"The effect of the vasoactive intestinal polypeptide agonist Ro 25-1553 on induced tone in isolated human airways and pulmonary artery","volume":"364","author":"Schmidt","year":"2001","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib146","first-page":"A686","article-title":"Tracheal relaxant response to vasoactive intestinal peptide (VIP): influence of airway epithelium and peptidases (abstract)","volume":"7","author":"Sharaf","year":"1993","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2005.12.055_bib147","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/pulp.1995.1011","article-title":"The distribution and density of airway vasoactive intestinal polypeptide (VIP) binding sites in cystic fibrosis and asthma","volume":"8","author":"Sharma","year":"1995","journal-title":"Pulm. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib148","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1152\/jappl.1988.65.6.2537","article-title":"VIP augments cholinergic-induced glycoconjugate secretion in tracheal submucosal glands","volume":"65","author":"Shimura","year":"1988","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib149","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0165-6147(02)02022-9","article-title":"Asthma \u2014 a need for a rethink?","volume":"23","author":"Spina","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2005.12.055_bib150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1094-5539(03)00049-X","article-title":"Calcitonin gene-related peptide as inflammatory mediator","volume":"16","author":"Springer","year":"2003","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2005.12.055_bib151","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.regpep.2003.11.006","article-title":"Effects of alpha calcitonin gene-related peptide in human bronchial smooth muscle and pulmonary artery","volume":"118","author":"Springer","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2005.12.055_bib152","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1006\/bbrc.1993.1658","article-title":"Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor","volume":"193","author":"Sreedharan","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2005.12.055_bib153","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1073\/pnas.92.7.2939","article-title":"Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene","volume":"92","author":"Sreedharan","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2005.12.055_bib154","doi-asserted-by":"crossref","first-page":"19617","DOI":"10.1016\/S0021-9258(18)41819-4","article-title":"Identity of a membrane-bound vasoactive intestinal peptide-binding protein with calmodulin","volume":"267","author":"Stallwood","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2005.12.055_bib155","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1006\/bbrc.1994.2852","article-title":"Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts","volume":"205","author":"Svoboda","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2005.12.055_bib156","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1165\/ajrcmb\/2.5.449","article-title":"Protease inhibitors potentiate smooth muscle relaxation induced by vasoactive intestinal peptide in isolated human bronchi","volume":"2","author":"Tam","year":"1990","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib157","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1089\/jir.1995.15.993","article-title":"Neuropeptide regulation of cytokine expression: effects of VIP and Ro 25-1553","volume":"15","author":"Tang","year":"1995","journal-title":"J. Interferon. Cytokine Res."},{"key":"10.1016\/j.ejphar.2005.12.055_bib158","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/en.131.1.73","article-title":"Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons","volume":"131","author":"Tatsuno","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2005.12.055_bib159","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1164\/ajrccm\/142.5.1119","article-title":"Enzymatic modulation of vasoactive intestinal peptide and nonadrenergic noncholinergic inhibitory responses in guinea pig tracheae","volume":"142","author":"Thompson","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejphar.2005.12.055_bib160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-2999(83)90012-2","article-title":"Inhibition by vasoactive intestinal peptide of antigen-induced histamine release from guinea-pig minced lung","volume":"88","author":"Undem","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib161","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1210\/en.135.6.2662","article-title":"Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions","volume":"135","author":"Usdin","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2005.12.055_bib162","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1183\/09031936.02.02542001","article-title":"Persistent asthma: disease control, resource utilisation and direct costs","volume":"20","author":"Van Ganse","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2005.12.055_bib163","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1096\/fj.01-0671com","article-title":"Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor","volume":"15","author":"Voice","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2005.12.055_bib164","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0167-0115(02)00182-9","article-title":"Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide","volume":"109","author":"Voice","year":"2002","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2005.12.055_bib165","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4049\/jimmunol.170.1.308","article-title":"Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice","volume":"170","author":"Voice","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib166","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0196-9781(97)00257-X","article-title":"Effects of VIP and related peptides on airway mucus secretion from isolated rat trachea","volume":"19","author":"Wagner","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2005.12.055_bib167","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1476-5381.1987.tb08992.x","article-title":"The effect of vasoactive intestinal peptide on smooth muscle tone and mucus secretion from the ferret trachea","volume":"91","author":"Webber","year":"1987","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib168","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1365-2826.1996.05191.x","article-title":"Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implications for their role in human physiology","volume":"8","author":"Wei","year":"1996","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2005.12.055_bib169","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1164\/ajrccm.158.supplement_2.13tac140","article-title":"Autonomic regulation. i-NANC\/e-NANC","volume":"158","author":"Widdicombe","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2005.12.055_bib170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1094-5539(02)00178-5","article-title":"Overview of neural pathways in allergy and asthma","volume":"16","author":"Widdicombe","year":"2003","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2005.12.055_bib171","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0022-3565(24)36654-6","article-title":"Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor","volume":"281","author":"Xia","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905013853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905013853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T18:30:21Z","timestamp":1736274621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905013853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":171,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0014299905013853"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.12.055","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}